Insulin therapy for type 2 diabetes mellitus
A Wallia, ME Molitch - Jama, 2014 - jamanetwork.com
Importance The incidence and prevalence of type 2 diabetes mellitus are increasing.
Objective To review currently available insulin therapy, as well as evidence on the use …
Objective To review currently available insulin therapy, as well as evidence on the use …
Identifying and meeting the challenges of insulin therapy in type 2 diabetes
C Sorli, MK Heile - Journal of multidisciplinary healthcare, 2014 - Taylor & Francis
Type 2 diabetes mellitus (T2DM) is a chronic illness that requires clinical recognition and
treatment of the dual pathophysiologic entities of altered glycemic control and insulin …
treatment of the dual pathophysiologic entities of altered glycemic control and insulin …
New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in …
MC Riddle, GB Bolli, M Ziemen… - Diabetes …, 2014 - Am Diabetes Assoc
OBJECTIVE To compare the efficacy and safety of new insulin glargine 300 units/mL (Gla-
300) with glargine 100 units/mL (Gla-100) in people with type 2 diabetes on basal insulin (≥ …
300) with glargine 100 units/mL (Gla-100) in people with type 2 diabetes on basal insulin (≥ …
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized …
MC Riddle, T Forst, R Aronson, L Sauque-Reyna… - Diabetes …, 2013 - Am Diabetes Assoc
OBJECTIVE When oral therapy for type 2 diabetes is ineffective, adding basal insulin
improves glycemic control. However, when glycated hemoglobin (HbA1c) remains elevated …
improves glycemic control. However, when glycated hemoglobin (HbA1c) remains elevated …
Faster aspart versus insulin aspart as part of a basal-bolus regimen in inadequately controlled type 2 diabetes: the onset 2 trial
K Bowering, C Case, J Harvey, M Reeves… - Diabetes …, 2017 - Am Diabetes Assoc
OBJECTIVE This multicenter, double-blind, treat-to-target, phase 3 trial evaluated the
efficacy and safety of fast-acting insulin aspart (faster aspart) versus insulin aspart (IAsp) in …
efficacy and safety of fast-acting insulin aspart (faster aspart) versus insulin aspart (IAsp) in …
An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study
AIM: The aim of A1chieve was to remedy the deficit of data on the efficacy and safety of
insulin analogues in routine clinical care in less well-resourced/newly developed countries …
insulin analogues in routine clinical care in less well-resourced/newly developed countries …
A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD‐ON)
Aim Two treatment strategies were compared in patients with type 2 diabetes (T2DM) on
basal insulin requiring intensification: addition of once‐daily (OD) liraglutide (Lira) or OD …
basal insulin requiring intensification: addition of once‐daily (OD) liraglutide (Lira) or OD …
Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American …
JM Gonzalez-Campoy, K Castorino… - Endocrine …, 2013 - endocrinepractice.org
2. METHODS The AACE Board of Directors mandated a CPG on healthy eating for the
prevention and treatment of metabolic and endocrine diseases in adults. The project was …
prevention and treatment of metabolic and endocrine diseases in adults. The project was …
Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to …
HW Rodbard, VE Visco, H Andersen… - The lancet Diabetes & …, 2014 - thelancet.com
Background We compared stepwise addition of bolus insulin with a full basal-bolus regimen
in patients with type 2 diabetes inadequately controlled on basal insulin plus oral …
in patients with type 2 diabetes inadequately controlled on basal insulin plus oral …
[HTML][HTML] Intensification of insulin therapy for type 2 diabetic patients in primary care: basal-bolus regimen versus premix insulin analogs: when and for whom?
O Mosenzon, I Raz - Diabetes Care, 2013 - ncbi.nlm.nih.gov
Association (ADA) and the European Association for the Study of Diabetes (EASD)
published a joint position statement regarding treatment of hyperglycemia in type 2 …
published a joint position statement regarding treatment of hyperglycemia in type 2 …